[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343268-105":59,"doc-detail-343268-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancer-and-immune-response-the-role-of-pd-1pd-l1-checkpoint-in-laryngeal-carcinoma-preliminary-results","Cancer and immune response: The role of PD-1/PD-L1 checkpoint in laryngeal carcinoma - Preliminary results","","Prospective evaluation of laryngeal squamous cell carcinoma (LSCC) examines how PD-1/PD-L1 checkpoint inhibition relates to immune suppression and outcomes. The study addresses the stagnant overall survival in advanced disease by analyzing clinicopathologic factors including sex, age, smoking and alcohol habits, serum C-reactive protein (CRP), tumor subsite, histopathologic grade, neck node status, stage, and PD-L1 expression quantified as Combined Positive Score (CPS). Results assess correlations among CPS, smoking, nodal stage, and CRP, supporting checkpoint involvement; further work is required to identify optimal patients for anti-PD-1/PD-L1 therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-and-immune-response-the-role-of-pd-1pd-l1-checkpoint-in-laryngeal-carcinoma-preliminary-results/343268/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-and-immune-response-the-role-of-pd-1pd-l1-checkpoint-in-laryngeal-carcinoma-preliminary-results/343268.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study on LSCC and PD-1/PD-L1?","Question",{"text":112,"@type":113},"To address the negative prognosis of advanced laryngeal squamous cell carcinoma by evaluating the role of the PD-1/PD-L1 checkpoint, which suppresses immune response, and how PD-L1 expression may relate to patient factors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which patient and tumor parameters were analyzed in the prospective study?",{"text":117,"@type":113},"Sex, age, smoking and alcohol habits, serum C-reactive protein (CRP), laryngeal subsite, differentiation-based histopathologic grading, neck node involvement, tumor stage, and PD-L1 expression measured as Combined Positive Score (CPS).",{"name":119,"@type":110,"acceptedAnswer":120},"What correlations were found between PD-L1 CPS and clinical variables?",{"text":121,"@type":113},"A statistically significant correlation was found between CPS and smoking habits and N stage. CRP increased in 44.83% of patients and showed a statistically significant correlation with CPS.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343268,1790939048,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","European Archives of Oto-Rhino-Laryngology (2024) 281:5411–5417  \n[https://doi.org/10.1007/s00405-024-08822-7](https://doi.org/10.1007/s00405-024-08822-7)  \nLARYNGOLOGY  \nCancer and immune response: The role of PD-1/PD-L1 checkpoint in laryngeal carcinoma. Preliminary results  \nBarbara Verro1 · Giuseppe Saraniti1 · Gaetano Ottoveggio2 · Carmelo Saraniti1  \nReceived: 2 May 2024 / Accepted: 1 July 2024 / Published online: 28 July 2024 © The Author(s) 2024  \nAbstract  \nPurpose The overall survival of laryngeal squamous cell carcinoma (LSCC) hasn’t changed significantly in the last decades, leading to a negative prognosis in advanced stages. So, the immunotherapy takes space with the inhibition of PD-1/PD-L1 checkpoint, involved in suppression of immune response.  \nMethods A prospective study was conducted on LSCC patients, selected according to strict criteria. The study was approved by the ethics committee of our Hospital. Parameters were: sex, age, smoking and alcohol habits, C-reactive protein (CRP) level in the serum, laryngeal subsite involved, differentiation-based histopathologic grading of tumor, neck node involvement, tumor stage, expression levels of PD-L1 (as Combined Positive Score – CPS) . P-value \u003C0.05 was statistically significant. Results 58 patients were included: 31.03% were females, mean age 63.55±10.09. A statistically significant correlation between CPS and smoking habits and N stage was found. CRP resulted increased in 44.83% of patients with a statistically significant correlation with CPS. The most cases were glottic cancers (46.55%) . 75.86% of tumors were moderately-differentiated, without correlation with CPS.  \nConclusion PD-L1 expression levels are variables independent of sex, age, alcohol consumption, differentiation degree of LSCC. A statistically significant correlation between PD-L1 expression levels and smoking habits, neck node status and CRP was found. This last finding demonstrates the involvement of PD-1/PD-L1 checkpoint in immune response in case of cancer. However, these results need further studies to detect the best patients tailored for treatment with anti-PD-1/PD-L1 blocking antibodies.  \nKeywords Laryngeal carcinoma · Biomarker · Prognosis · Treatment · Immunotherapy  \nIntroduction  \nLaryngeal squamous cell carcinoma (LSCC) is among the most prevalent head and neck cancers worldwide [1] . In the last years, despite the overall incidence of LSCC is decreased [2] and despite advancements in diagnostic tools, around 60% of LSCC are still diagnosed at advances stages [3] resulting in a declining 5-year survival rate [2] . Based  \n􀀍 Barbara Verro [barbara.verro@unipa.it](barbara.verro@unipa.it)  \n1 Unit of Otorhinolaryngology, Department of Biomedicine, Neuroscience and Advanced Diagnostic (BIND), University of Palermo, Palermo, Italy  \n2 Unit of Anesthesia, Intensive Care, and Emergency, Department of Surgical, Oncological and Oral Science (Di. Chir.On.S.), University of Palermo, Palermo, Italy  \non these assumptions, the main goal of oncology is to formulate a customized therapy in order to ensure the best prognosis to patient. So, in this context, the immunotherapy has emerged as a significant approach, particularly with the inhibition of PD-1/PD-L1 (programmed cell death protein – 1 / programmed cell death 1 ligand 1) checkpoint, which plays a crucial role in immune response suppression [4] . In 1992, Tasuku Honjo found that protein PD-1, expressed on T cells surface, brakes its activity. This discovering paved the way to the use of PD-1 as a target for therapy against cancer. PD-L1, expressed by tumor cells, binds to the receptor PD-1 on T cells, leading to inhibition of their anti-tumor role [5] and to induction and maintenance of immune tolerance within the tumor microenvironment. In particular, PD-1/PD-L1 axis inhibits activation, proliferation, survival  \nand cytotoxic secretion ofT cells within cancer cells [6] .  \nStudies found that administration of anti-PD-1/PD-L1 blocking ant","cbCaipu3oOK1m9GJ","https://ap.wps.com/l/cbCaipu3oOK1m9GJ","pdf",979432,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background and rationale\n## Evidence for PD-1/PD-L1 blockade","[{\"question\":\"What is the main purpose of the study on LSCC and PD-1/PD-L1?\",\"answer\":\"To address the negative prognosis of advanced laryngeal squamous cell carcinoma by evaluating the role of the PD-1/PD-L1 checkpoint, which suppresses immune response, and how PD-L1 expression may relate to patient factors.\"},{\"question\":\"Which patient and tumor parameters were analyzed in the prospective study?\",\"answer\":\"Sex, age, smoking and alcohol habits, serum C-reactive protein (CRP), laryngeal subsite, differentiation-based histopathologic grading, neck node involvement, tumor stage, and PD-L1 expression measured as Combined Positive Score (CPS).\"},{\"question\":\"What correlations were found between PD-L1 CPS and clinical variables?\",\"answer\":\"A statistically significant correlation was found between CPS and smoking habits and N stage. CRP increased in 44.83% of patients and showed a statistically significant correlation with CPS.\"}]","Cancer and immune response: The role of PD-1/PD-L1 checkpoint in laryngeal carcinoma - Preliminary results | PDF",1790050523,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abec4394b594fe10d183f7bc8b85ca64.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d232940f8a646482e42ac0285b95d33.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbc3916679a6dea1442fbda917772e97.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db49fb08dccea56b84d17744ff81e173.webp",980,1301]